Evolus Investor Presentation March 2024

Evolus presents forward-looking business strategy and financial outlook for 2024, detailing commercialization plans for Jeuveau and development of product candidates including Evolysse. The presentation addresses market dynamics, clinical program progress, and regulatory pathways for aesthetic medicine solutions.